Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structure supports the construction of complex piperazine-based drugs, often explored for their antipsychotic, antidepressant, or anticonvulsant activities. The presence of an amino group and trifluoromethyl moiety enhances binding affinity to specific receptors, making it valuable in medicinal chemistry for structure-activity relationship studies. Commonly employed in research settings to design novel therapeutic agents.